These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18807485)

  • 41. [HIV/HCV coinfection. A good chance of recovery also for dually infected patients].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():7. PubMed ID: 25026843
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.
    García-Samaniego J; Soriano V; Miró JM; Romero JD; Bruguera M; Castilla J; Esteban JI; Gonźlez J; Lissen E; Moreno A; Moreno S; Moreno-Otero R; Ortega E; Quereda C; Rodríguez M; Sánchez-Tapias JM;
    HIV Clin Trials; 2002; 3(2):99-114. PubMed ID: 11976988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The program of early detection of HCV infection].
    Borzecka B; Błudzin W
    Przegl Epidemiol; 2007; 61(4):733-8. PubMed ID: 18572505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of patients coinfected by HCV and HIV.
    Poynard T
    Med J Malaysia; 2005 Jul; 60 Suppl B():70-1. PubMed ID: 16108178
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hepatitis C in HIV infected patients].
    Bukh J; Nielsen JO
    Ugeskr Laeger; 2006 Oct; 168(42):3599. PubMed ID: 17069719
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evidence-based medicine tratment of chronic viral hepatitis B and C].
    Ledro Cano D; Gómez Parra M; Jiménez Sáenz M; Ledro Molina D; Herrerías Gutiérrez JM
    An Med Interna; 2000 Dec; 17(12):660-4. PubMed ID: 11213585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis B and C in HIV coinfection].
    Fehr J; Schärer V; Hirzel C; Rauch A
    Ther Umsch; 2014 Aug; 71(8):490-6. PubMed ID: 25093314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C in children: recent advances.
    Zein NN
    Curr Opin Pediatr; 2007 Oct; 19(5):570-4. PubMed ID: 17885477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients.
    Soriano V; Rodríguez-Rosado R; Pérez-Olmeda M; Romero M; García-Samaniego J
    AIDS; 2000 Oct; 14(15):2409-10. PubMed ID: 11089634
    [No Abstract]   [Full Text] [Related]  

  • 50. [Vaniprevir with pegylated interferon and ribavirin in treatment for chronic hepatitis C].
    Takehara T
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():254-6. PubMed ID: 26845940
    [No Abstract]   [Full Text] [Related]  

  • 51. [Chronic hepatitis C from the viewpoint of the patients. There are many causes for the quality of life of patients with chronic hepatitis C to be impaired. But there also exist many possibilities to change it].
    MMW Fortschr Med; 2002 Nov; 144(48):59. PubMed ID: 12532549
    [No Abstract]   [Full Text] [Related]  

  • 52. [To treat or not to treat: the indications and contraindications for the use of interferon in chronic viral hepatitis].
    Piccinino F; Piccinino R; Scolastico C
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):89-96. PubMed ID: 7542488
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hepatitis C in women planning a pregnancy: current opinions].
    Langlet P; Lasser L; Sidi B
    Rev Med Brux; 2005; 26(6):487-91. PubMed ID: 16454152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of treatment non responders in chronic hepatitis C.
    Poynard T
    Med J Malaysia; 2005 Jul; 60 Suppl B():77-9. PubMed ID: 16108180
    [No Abstract]   [Full Text] [Related]  

  • 55. [Endocrinal dysfunctions in liver failure of different etiologies and during interferon therapy in patients with chronic hepatitis B and C].
    Lapiński TW; Dabrowska MM
    Pol Merkur Lekarski; 2008 May; 24(143):468-71. PubMed ID: 18634398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
    Phillips E; Hayden A; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2008 Feb; 22(4):548-9. PubMed ID: 18301076
    [No Abstract]   [Full Text] [Related]  

  • 57. [Significance of health related quality of life in assessing curative effect for chronic hepatitis C].
    Jin CH; Yao GB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):190-2. PubMed ID: 15059317
    [No Abstract]   [Full Text] [Related]  

  • 58. Indication of prolonged interferon therapy for chronic hepatitis C.
    Okanoue T; Itoh Y
    J Gastroenterol; 2003; 38(2):204-5. PubMed ID: 12640541
    [No Abstract]   [Full Text] [Related]  

  • 59. Watch co-infected patients more closely.
    AIDS Patient Care STDS; 2005 Apr; 19(4):272. PubMed ID: 15857199
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of chronic hepatitis C in pediatric patients.
    Jonas MM
    Clin Liver Dis; 1999 Nov; 3(4):855-67. PubMed ID: 11291255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.